newsfilter
← Latest News
Business Wire·

NeoGenomics to Present New Research at ASCO Annual Meeting 2026

Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions